William Dall'Acqua

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
MEDIMMUNE, INC.
1
2008
MEDIMMUNE LIMITED
2
1
1
2
2009
2013
2014
2016
MEDIMMUNE, LLC
1
1
4
7
6
3
1
5
4
4
3
6
1
2001
2003
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2016
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
1
2
2
2
2
2
2
2
2001
2006
2007
2010
2011
2012
2013
2014
LUDWIG INSTITUTE FOR CANCER RESEARCH
1
1
2003
2008

Inventor Addresses

AddressDuration
GAITHERSBURG, MD, USJun 30, 11 - Apr 18, 24
Gaithersburg, MDAug 18, 05 - Dec 04, 08
Gaithersburg, MD, USSep 03, 09 - Dec 19, 24

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 34
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 9
C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 11

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2024/0417,4602024HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE0
2024/0124,6122024MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES0
117673692023Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties0
2021/0061,9062021HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE1
2020/0071,4232020MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.